This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Leland Stanford Junior University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Jacob J Chabon: Innovator in Nucleic Acid Analysis
Introduction
Jacob J Chabon is a prominent inventor based in Arvada, Colorado. He has made significant contributions to the field of nucleic acid analysis, particularly in the context of cancer detection and genetic abnormalities. With a total of 2 patents, his work is at the forefront of medical diagnostics.
Latest Patents
Chabon's latest patents include innovative methods for analyzing cell-free nucleic acids. One patent describes processes and materials to detect neoplasms from a biopsy. This includes the development of processes to build a sequencing library and perform targeted sequencing. Additionally, it outlines methods to mitigate confounding sources in sequencing results. His work allows for the sequencing of cell-free nucleic acids, which can be utilized to detect sequences derived from neoplasms. Another patent focuses on methods and systems for analyzing nucleic acid molecules. This includes processes to detect cancer, transplant rejection, or fetal genetic abnormalities from a biopsy. The sequencing results can indicate the presence of these conditions, enabling timely clinical interventions.
Career Highlights
Jacob J Chabon is affiliated with Leland Stanford Junior University, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
Chabon has collaborated with notable colleagues, including Maximilian Diehn and Arash Ash Alizadeh. Their combined expertise enhances the impact of their research in nucleic acid analysis.
Conclusion
Jacob J Chabon is a key figure in the innovation of nucleic acid analysis, with patents that significantly contribute to medical diagnostics. His work continues to pave the way for advancements in cancer detection and genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
